122 related articles for article (PubMed ID: 1605141)
41. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
42. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients.
Li S; Wang H; Hu J; Li N; Liu Y; Wu Z; Zheng Y; Wang H; Wu K; Ye H; Rao J
Int J Cancer; 2006 Jun; 118(12):3078-83. PubMed ID: 16425283
[TBL] [Abstract][Full Text] [Related]
43. Fecal immunological blood test is more appealing than the guaiac-based test for colorectal cancer screening.
Le Pimpec F; Moutel G; Piette C; Lièvre A; Bretagne JF
Dig Liver Dis; 2017 Nov; 49(11):1267-1272. PubMed ID: 28867474
[TBL] [Abstract][Full Text] [Related]
44. ROUTINE CHEMICAL TESTS OF THE STOOL FOR OCCULT BLOOD: AN EVALUATION.
IRONS GV; KIRSNER JB
Am J Med Sci; 1965 Mar; 249():247-60. PubMed ID: 14273312
[No Abstract] [Full Text] [Related]
45. Fecal occult blood testing: clinical value and limitations.
Simon JB
Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
[TBL] [Abstract][Full Text] [Related]
46. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.
Castiglione G; Zappa M; Grazzini G; Mazzotta A; Biagini M; Salvadori P; Ciatto S
Br J Cancer; 1996 Jul; 74(1):141-4. PubMed ID: 8679448
[TBL] [Abstract][Full Text] [Related]
47. The cost-effectiveness of immunochemical tests for colorectal cancer screening.
Lejeune C; Le Gleut K; Cottet V; Galimard C; Durand G; Dancourt V; Faivre J
Dig Liver Dis; 2014 Jan; 46(1):76-81. PubMed ID: 24012177
[TBL] [Abstract][Full Text] [Related]
48. Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: evidentiary base and recommendations.
Rabeneck L; Zwaal C; Goodman JH; Mai V; Zamkanei M
Clin Biochem; 2008 Nov; 41(16-17):1289-305. PubMed ID: 18796300
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection.
Nemat H; Khan R; Ashraf MS; Matta M; Ahmed S; Edwards BT; Hussain R; Lesser M; Pekmezaris R; Dlugacz Y; Wolf-Klein G
Am J Gastroenterol; 2009 Aug; 104(8):2035-41. PubMed ID: 19367273
[TBL] [Abstract][Full Text] [Related]
50. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.
Chausserie S; Levillain R; Puvinel J; Ferrand O; Ruiz A; Raginel T; Lantieri O; Launoy G; Guittet L
Int J Cancer; 2015 Apr; 136(8):1827-34. PubMed ID: 25195670
[TBL] [Abstract][Full Text] [Related]
51. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis.
Vart G; Banzi R; Minozzi S
Prev Med; 2012 Aug; 55(2):87-92. PubMed ID: 22634386
[TBL] [Abstract][Full Text] [Related]
52. [Validity of proton pump inhibitors' prescriptions in a department of internal medicine].
Marie I; Moutot A; Tharrasse A; Hellot MF; Robaday S; Hervé F; Lévesque H
Rev Med Interne; 2007 Feb; 28(2):86-93. PubMed ID: 17092611
[TBL] [Abstract][Full Text] [Related]
53. Thyroid screening tests in psychiatric inpatients.
Enns M; Ross C; Clark P
Gen Hosp Psychiatry; 1992 Sep; 14(5):334-9. PubMed ID: 1521789
[TBL] [Abstract][Full Text] [Related]
54. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
Brenner H; Hoffmeister M; Birkner B; Stock C
Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
[TBL] [Abstract][Full Text] [Related]
55. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
56. Rapid immunochemical detection of fecal occult blood by use of a latex-agglutination test.
Väänänen P; Tenhunen R
Clin Chem; 1988 Sep; 34(9):1763-6. PubMed ID: 3416425
[TBL] [Abstract][Full Text] [Related]
57. [Evaluation in hospital practice of Fecatest, a new laboratory method for the detection of occult blood in feces].
Brault J; Favre H
Schweiz Med Wochenschr; 1979 Jan; 109(3):73-6. PubMed ID: 760190
[TBL] [Abstract][Full Text] [Related]
58. Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests.
Harewood GC; McConnell JP; Harrington JJ; Mahoney DW; Ahlquist DA
Mayo Clin Proc; 2002 Jan; 77(1):23-8. PubMed ID: 11794453
[TBL] [Abstract][Full Text] [Related]
59. Differences in Routine Laboratory Ordering Between a Teaching Service and a Hospitalist Service at a Single Academic Medical Center.
Ellenbogen MI; Ma M; Christensen NP; Lee J; O'Leary KJ
South Med J; 2017 Jan; 110(1):25-30. PubMed ID: 28052170
[TBL] [Abstract][Full Text] [Related]
60. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive.
Gordon JC; Steele RJ; Fraser CG
Ann Clin Biochem; 2004 Nov; 41(Pt 6):488-90. PubMed ID: 15588441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
